Search Results - Jake T. Liang

Refine Results
  1. 1
    Hepatitis B: The virus and disease

    Hepatitis B: The virus and disease by Jake T. Liang

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Hepatitis C — Identifying Patients with Progressive Liver Injury

    Hepatitis C — Identifying Patients with Progressive Liver Injury by Jordan J. Feld, Jake T. Liang

    Published 2006
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Hepatitis C virus entry: Molecular biology and clinical implications

    Hepatitis C virus entry: Molecular biology and clinical implications by Heidi Barth, Jake T. Liang, Thomas F. Baumert

    Published 2006
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers

    Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers by Jake T. Liang, Hubert E. Blum, Jack R. Wands

    Published 1990
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection

    Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection by Hubert E. Blum, Jake T. Liang, Eithan Galun, Jack R. Wands

    Published 1991
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

    Mechanism of action of ribavirin in the combination treatment of chronic HCV infection by Johnson Y. N. Lau, Robert C. Tam, Jake T. Liang, Zhi Hong

    Published 2002
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

    The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease by Yaron Rotman, Christopher Koh, Joseph M. Zmuda, David E. Kleiner, Jake T. Liang

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models

    Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models by Emmanuel Thomas, Jordan J. Feld, Qisheng Li, Zongyi Hu, Michael Fried, Jake T. Liang

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Hepatitis C virus–like particles induce virus-specific humoral and cellular immune responses in mice

    Hepatitis C virus–like particles induce virus-specific humoral and cellular immune responses in mice by Martin Lechmann, Kazumoto Murata, Jujin Satoi, John Vergalla, Thomas F. Baumert, Jake T. Liang

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop

    Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop by Raymond T. Chung, Michael Gale, Stephen J. Polyak, Stanley M. Lemon, Jake T. Liang, Jay H. Hoofnagle

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Increased caffeine consumption is associated with reduced hepatic fibrosis

    Increased caffeine consumption is associated with reduced hepatic fibrosis by Apurva A. Modi, Jordan J. Feld, Yoon Park, David E. Kleiner, James E. Everhart, Jake T. Liang, Jay H. Hoofnagle

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients

    Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients by Birgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta, Jonathan Stoltzfus, Mazen Noureddin, Elisavet Serti, Jordan J. Feld, Jake T. Liang, Yaron Rotman, Barbara Rehermann

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection

    Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection by Nabora Soledad Reyes de Mochel, Scott Seronello, Shelley Hsiuying Wang, Chieri Ito, Jasper Xi Zheng, Jake T. Liang, David Lambeth, Jinah Choi

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Hepatitis B virus infection in patients with idiopathic liver disease

    Hepatitis B virus infection in patients with idiopathic liver disease by Jake T. Liang, Yaacov Baruch, E Ben‐Porath, R Enat, Lucyna Bassan, Nancy V. Brown, Nurit Rimon, Hubert E. Blum, Jack R. Wands

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation

    Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation by Takanobu Kato, You-kyung Choi, Gamal A. Elmowalid, Ronda K. Sapp, Heidi Barth, Akihiro Furusaka, Shunji Mishiro, Takaji Wakita, Krzysztof Krawczynski, Jake T. Liang

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response

    Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response by Jordan J. Feld, Santosh Kumar Nanda, Ying Huang, Weiping Chen, Maggie Cam, Susan N. Pusek, Lisa M. Schweigler, Dickens Theodore, Steven Zacks, Jake T. Liang, Michael Fried

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: A longitudinal analysis

    Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: A longitudinal analysis by Mazen Noureddin, Elizabeth C. Wright, Harvey J. Alter, Shauna Clark, Emmanuel Thomas, Richard Chen, Xiongce Zhao, Cathy Conry‐Cantilena, David E. Kleiner, Jake T. Liang, Marc G. Ghany

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Long-Term Therapy of Chronic Hepatitis B With Lamivudine

    Long-Term Therapy of Chronic Hepatitis B With Lamivudine by Daryl Lau, Farooq Khokhar, Edward Doo, Marc G. Ghany, David Herion, Yoon Park, David E. Kleiner, Peter Schmid, Lynn D. Condreay, Josée Gauthier, Mary C. Kuhns, Jake T. Liang, Jay H. Hoofnagle

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin

    Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin by Jay H. Hoofnagle, Marc G. Ghany, David E. Kleiner, Edward Doo, Theo Heller, Kittichai Promrat, Janus P. Ong, Farooq Khokhar, Alejandro Soza, David Herion, Yoon Park, James E. Everhart, Jake T. Liang

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

    A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis by Kittichai Promrat, Glen Lutchman, Gabriel I. Uwaifo, Reneé J. Freedman, Alejandro Soza, Theo Heller, Edward Doo, Marc G. Ghany, Ahalya Premkumar, Yoon Park, Jake T. Liang, Jack A. Yanovski, David E. Kleiner, Jay H. Hoofnagle

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: